文献速递关节外科

模块化钽块联合非骨水泥钽杯重建严重髋臼缺损全髋关节置换术后患者血钽浓度升高

Elevated Blood Tantalum Concentrations in Patients Following Reconstruction of Severe Acetabular Defects in Total Hip Arthroplasty Using Modular Tantalum Augments in Combination With Uncemented Tantalum Cups.
PubMed 文献 · J Arthroplasty · 2024-05-31

单中心回顾性分析27例使用模块化钽块联合非骨水泥钽杯重建严重髋臼缺损的复杂全髋关节置换患者,平均随访4.5年。以无菌性松动翻修为终点的4.5年累积生存率为94.4%,任何原因翻修为82.9%;患者报告结局评分显著改善,影像学无松动或移位征象。研究组血钽浓度中位数0.15 μg/L,显著高于对照组0.002 μg/L(P < .001)。

要点

  • 模块化钽块联合非骨水泥钽杯重建严重髋臼缺损,4.5年无菌性松动翻修生存率94.4%。
  • 任何原因翻修生存率82.9%,患者报告结局评分显著改善,影像学无松动或移位。
  • 研究组血钽浓度中位数0.15 μg/L,显著高于对照组0.002 μg/L(P < .001)。

核心结论

  • 使用模块化小梁金属植入物进行非骨水泥翻修全髋关节置换重建大髋臼缺损,临床和影像学结果可接受。
  • 有钽植入物的患者血钽浓度显著高于对照组,但钽暴露增加的系统性和局部效应尚未完全明确,需进一步研究。

研究设计与样本

  • 单中心回顾性研究,连续纳入27例使用模块化钽髋臼块联合非骨水泥钽杯行复杂髋臼缺损重建的患者。
  • 评估植入物生存率、影像学和临床结果,平均随访4.5年(标准差2.1,范围2.5至10.6年),并使用患者报告结局评分。
  • 分析血样本钽浓度并与对照组比较。

主要发现

  • 以无菌性松动翻修髋臼组件为终点的4.5年累积生存率为94.4%(95%CI 71.6至99.2)。
  • 以任何原因翻修为终点的4.5年累积生存率为82.9%(95%CI 60.5至93.3)。
  • 患者报告结局评分至末次随访显著改善,影像学数据未显示松动或植入物移位征象。
  • 研究组血钽浓度中位数为0.15 μg/L,显著高于对照组的0.002 μg/L(P < .001)。

局限性

  • 临床数据关于该治疗策略的长期结果有限。
  • 钽暴露增加的系统性和局部效应尚未完全明确,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The reconstruction of acetabular defects in total hip arthroplasty (THA) can be challenging. An option to treat uncontained acetabular defects is to use modular tantalum augments in combination with cementless press-fit cups. However, modularity is associated with an increased risk of debonding and mechanical failure. In addition, metal wear particles can be released due to micromotions at the implant interface. Clinical data on the long-term results of this treatment strategy is limited. The purposes of this study were: (1) to evaluate the clinical and radiological outcome of complex THA using modular trabecular metal augments and uncemented revision cups; (2) to investigate the blood tantalum concentrations in these patients at mid-term (mean 4.5 year) follow-up; and (3) to report complications and mechanisms of failure related to this procedure. METHODS: In this single-center study, we retrospectively reviewed data from a consecutive cohort of 27 patients who underwent complex acetabular defect reconstruction using a modular tantalum acetabular augment in combination with an uncemented tantalum cup. We evaluated the implant survival, and the radiological and clinical outcomes after a mean follow-up of 4.5 years (standard deviation 2.1; range 2.5 to 10.6 years) using patient-reported outcome scores. Blood samples were analyzed regarding tantalum concentration and compared with a control group. RESULTS: The cumulative survival rate at 4.5 years with the end point "revision of the acetabular component for aseptic loosening" was 94.4% (95% confidence interval [CI] 71.6 to 99.2) and 82.9% (95% CI 60.5 to 93.3) for the end point "revision for any reason." The patient-reported outcome scores improved significantly up to the latest follow-up, and radiographic data showed no signs of loosening or implant migration. Median blood tantalum concentrations were significantly higher in the study group (0.15 μg/L) compared to the control group (0.002 μg/L) (P < .001). CONCLUSIONS: This study demonstrated acceptable clinical and radiological results of cementless revision THA using modular trabecular metal implants for the reconstruction of large acetabular defects. Tantalum concentrations were significantly higher in patients who had tantalum implants compared to the control group; however, the systemic and local effects of an increased tantalum exposure are not yet fully understood and have to be further investigated.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Spranz D, Müller LM, Trefzer R, et al. Elevated Blood Tantalum Concentrations in Patients Following Reconstruction of Severe Acetabular Defects in Total Hip Arthroplasty Using Modular Tantalum Augments in Combination With Uncemented Tantalum Cups. J Arthroplasty. 2024. PMID: 38823519. doi:10.1016/j.arth.2024.05.068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。